Reginald Edward Greene, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aspergillosis | 5 | 2007 | 243 | 0.820 |
Why?
|
| Lung Diseases, Fungal | 3 | 2007 | 126 | 0.780 |
Why?
|
| Amphotericin B | 2 | 2007 | 142 | 0.340 |
Why?
|
| Radiography, Thoracic | 8 | 2014 | 1296 | 0.310 |
Why?
|
| Triazoles | 3 | 2007 | 902 | 0.280 |
Why?
|
| Lung | 9 | 2021 | 9985 | 0.250 |
Why?
|
| Models, Economic | 1 | 2007 | 715 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2021 | 20500 | 0.170 |
Why?
|
| Lung Diseases | 4 | 2014 | 1910 | 0.160 |
Why?
|
| Subtraction Technique | 1 | 2002 | 510 | 0.160 |
Why?
|
| Radiographic Image Enhancement | 3 | 2014 | 875 | 0.160 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2012 | 662 | 0.160 |
Why?
|
| Pyrimidines | 2 | 2007 | 3006 | 0.150 |
Why?
|
| Antifungal Agents | 3 | 2006 | 749 | 0.130 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
| Silicones | 1 | 2012 | 227 | 0.090 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 319 | 0.090 |
Why?
|
| Chronobiology Disorders | 1 | 2010 | 72 | 0.080 |
Why?
|
| Allied Health Personnel | 1 | 2010 | 155 | 0.080 |
Why?
|
| Berylliosis | 1 | 1988 | 9 | 0.080 |
Why?
|
| Stomach Diseases | 1 | 1989 | 133 | 0.080 |
Why?
|
| Pulmonary Circulation | 1 | 2009 | 743 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 551 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 1005 | 0.070 |
Why?
|
| Decision Trees | 1 | 2007 | 504 | 0.060 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2005 | 12 | 0.060 |
Why?
|
| Aspergillus fumigatus | 1 | 2005 | 156 | 0.060 |
Why?
|
| Myeloproliferative Disorders | 1 | 2009 | 606 | 0.050 |
Why?
|
| Asbestosis | 1 | 2002 | 81 | 0.050 |
Why?
|
| Pleural Cavity | 1 | 2021 | 25 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2006 | 856 | 0.050 |
Why?
|
| HIV Infections | 3 | 2012 | 17275 | 0.050 |
Why?
|
| Pleural Diseases | 1 | 2002 | 137 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2009 | 909 | 0.050 |
Why?
|
| Pneumonia | 1 | 2012 | 2129 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2006 | 1268 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 2634 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 2009 | 699 | 0.040 |
Why?
|
| Radiology | 1 | 2010 | 2102 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2012 | 2569 | 0.030 |
Why?
|
| Survival Rate | 2 | 2007 | 12721 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2012 | 9266 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3217 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5484 | 0.030 |
Why?
|
| Respiratory Function Tests | 2 | 2009 | 1680 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2006 | 10112 | 0.030 |
Why?
|
| Humans | 20 | 2021 | 758381 | 0.030 |
Why?
|
| Endotoxins | 1 | 1994 | 521 | 0.020 |
Why?
|
| Adult | 9 | 2014 | 219916 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15225 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 677 | 0.020 |
Why?
|
| Middle Aged | 9 | 2014 | 219560 | 0.020 |
Why?
|
| Nitrogen Radioisotopes | 1 | 2009 | 41 | 0.020 |
Why?
|
| Stomach Ulcer | 1 | 1989 | 122 | 0.020 |
Why?
|
| Supine Position | 1 | 2009 | 205 | 0.020 |
Why?
|
| Tungsten Compounds | 1 | 1988 | 10 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 1994 | 688 | 0.020 |
Why?
|
| Tungsten | 1 | 1988 | 19 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1994 | 1529 | 0.020 |
Why?
|
| Bronchiectasis | 1 | 2010 | 139 | 0.020 |
Why?
|
| Male | 11 | 2014 | 358742 | 0.020 |
Why?
|
| Metallurgy | 1 | 1988 | 95 | 0.020 |
Why?
|
| Cobalt | 1 | 1988 | 154 | 0.020 |
Why?
|
| Transsexualism | 1 | 2012 | 206 | 0.020 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2010 | 196 | 0.020 |
Why?
|
| Aged | 7 | 2014 | 168217 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 378 | 0.020 |
Why?
|
| Cough | 1 | 2012 | 594 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 651 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12951 | 0.020 |
Why?
|
| Aspergillus | 1 | 2006 | 92 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15396 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 1994 | 1305 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2010 | 80170 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2009 | 1871 | 0.010 |
Why?
|
| Dogs | 1 | 1989 | 3838 | 0.010 |
Why?
|
| Adolescent | 3 | 2009 | 87888 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20052 | 0.010 |
Why?
|
| Dyspnea | 1 | 2012 | 1344 | 0.010 |
Why?
|
| Female | 8 | 2014 | 390316 | 0.010 |
Why?
|
| Radiography | 2 | 1994 | 6955 | 0.010 |
Why?
|
| ROC Curve | 1 | 1989 | 3563 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1988 | 1486 | 0.010 |
Why?
|
| Sepsis | 1 | 1994 | 2587 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1989 | 1422 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 3997 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14641 | 0.010 |
Why?
|
| Biopsy | 1 | 2010 | 6768 | 0.010 |
Why?
|
| Child | 1 | 2006 | 79813 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 2002 | 496 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2210 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1994 | 9160 | 0.010 |
Why?
|
| Oxygen | 1 | 1988 | 4192 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1989 | 3732 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11070 | 0.010 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1994 | 25 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13468 | 0.010 |
Why?
|
| HIV-1 | 1 | 2012 | 6850 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6457 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 8946 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 64379 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13276 | 0.010 |
Why?
|
| Spirometry | 1 | 1994 | 923 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42058 | 0.010 |
Why?
|
| Time Factors | 2 | 1994 | 39873 | 0.010 |
Why?
|
| X-Ray Intensifying Screens | 1 | 1989 | 32 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 1988 | 25953 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1994 | 1812 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1994 | 910 | 0.000 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1988 | 94 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1988 | 962 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 58681 | 0.000 |
Why?
|
| Carbon Monoxide | 1 | 1988 | 540 | 0.000 |
Why?
|
| Linear Models | 1 | 1994 | 5861 | 0.000 |
Why?
|
| Respiratory Sounds | 1 | 1988 | 697 | 0.000 |
Why?
|
| Absorptiometry, Photon | 1 | 1989 | 1735 | 0.000 |
Why?
|
| Forced Expiratory Volume | 1 | 1988 | 1806 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 58808 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1994 | 12262 | 0.000 |
Why?
|
| United States | 1 | 1988 | 72140 | 0.000 |
Why?
|
| Animals | 1 | 1989 | 167777 | 0.000 |
Why?
|
| Incidence | 1 | 1994 | 21273 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 39060 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1994 | 54136 | 0.000 |
Why?
|
| Risk Factors | 1 | 1994 | 73806 | 0.000 |
Why?
|